|
| ID |
DDInter1508 |
| Drug Type |
small molecule |
| Molecular Formula |
C20H20Fno3S |
| Molecular Weight |
373.448
|
| Description |
Prasugrel is a P2Y12 platelet inhibitor used to reduce risk of thrombotic cardiovascular events in unstable angina or non-ST-elevation myocardial infarction (NSTEMI), and in patients with STEMI when managed with either primary or delayed PCI.
|
| ATC Classification |
B01AC22
|
| IUPAC Name |
5-[2-Cyclopropyl-1-(2-Fluorophenyl)-2-Oxoethyl]-4H,5H,6H,7H-Thieno[3,2-C]Pyridin-2-Yl Acetate |
| InChI |
Inchi=1S/C20H20Fno3S/C1-12(23)25-18-10-14-11-22(9-8-17(14)26-18)19(20(24)13-6-7-13)15-4-2-3-5-16(15)21/H2-5,10,13,19H,6-9,11H2,1H3 |
| InChI Key |
DTGLZDAWLRGWQN-UHFFFAOYSA-N |
| Canonical SMILES |
CC(=O)OC1=CC2=C(CCN(C2)C(C(=O)C2CC2)C2=CC=CC=C2F)S1 |
| Useful Links |
DrugBank
ChEMBL
PubChem
|